Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.430
-0.030 (-2.05%)
Oct 29, 2025, 4:00 PM EDT - Market closed
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $32.01 million as of October 30, 2025. Its market cap has decreased by -52.37% in one year.
Market Cap
32.01M
Enterprise Value
-45.63M
1-Year Change
-52.37%
Ranking
Category
Stock Price
$1.43
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $32.01M, a decrease of -91.00%. That is a compound annual growth rate of -78.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 32.68M | -49.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 449.42B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |